Was away from a computer most of the day. Not the announcement I was expecting, but nothing bad either.
Gives a couple more days for people to join the ride!
I agree, some of the criticisms previously was of the high market cap. At 0.8c fully diluted its less than $40 million. That assumes the 150% premium bones shares are issued and EDITDA of over $5 million per annum. I will admit, they are not huge hurdles, but the SP % rise is directly aligned with shareholders interests and at least the revenue targets are about cash and not something abstract.
Its not super low but still has plenty of room to rise when compared to the zero revenue zero profit companies with non-proven products trading at much higher valuations in my opinion.
Add to My Watchlist
What is My Watchlist?